BridgeMD
New treatment option for Hereditary Angioedema (HAE)
Official title A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema
ClinicalTrials.gov ID: NCT07293364
What this study is testing
- What it's testing
- Hereditary angioedema (HAE) is a rare condition. It causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older
You may be able to join if
- Adult and pediatric participants of both sexes (children over the age of 12 years).
- Participants providing a signed informed consent form (ICF), or parental consent for minors.
- Participants should also meet one of the 2 below:
- Participants with a high suspicion of bradykinin-mediated HAE, referred to the center. This includes recurrent episodes of nonpitting angioedema...
- Family members (from 1st to 4th degree relatives) of known HAE participants.
You likely can't join if
- Confirmed diagnosis of HAE-C1INH-Type1 or HAE-C1INH-Type2.
- Angioedema with urticaria or itching (suggesting histaminergic etiology).
- Angioedema episodes lasting less than (\ )5 days (not consistent with bradykinin-mediated HAE).
- Any condition deemed unsuitable by the investigator that may interfere with study procedures or data integrity.
The study team makes the final eligibility decision.
Where it's taking place
- Algiers, Algeria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Algiers, Algeria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.